Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 276,207 | 133,477 | 0 | 0 | N/A |
| TOTAL | $278,673 | $134,336 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,007 | 1,154 | N/A | N/A | N/A |
| Other Non-Current Assets | 341 | 3,998 | 0 | 0 | 0 |
| TOTAL | $1,348 | $5,152 | $N/A | $N/A | $N/A |
| Total Assets | $280,021 | $139,488 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,951 | 1,927 | 0 | 0 | 0 |
| Accrued Expenses | 6,592 | 5,462 | 0 | 0 | N/A |
| Other current liabilities | N/A | 9,123 | 0 | 0 | N/A |
| TOTAL | $18,708 | $16,837 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 194,090 | 0 | 0 | 0 |
| TOTAL | $N/A | $194,090 | $N/A | $N/A | $N/A |
| Total Liabilities | $18,708 | $210,927 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,842 | 32,764 | N/A | N/A | N/A |
| Common Shares | 32 | 2 | 0 | 0 | N/A |
| Retained earnings | -91,718 | -74,889 | 0 | 0 | N/A |
| TOTAL | $261,313 | $-71,439 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $280,021 | $139,488 | $0 | $0 | $0 |